Elevance Reports Fourth-Quarter Earnings That Are ‘Better Than Feared’
-
Jan 24, 2025
Elevance Health, Inc.’s fourth-quarter 2024 earnings report was better than many analysts expected after its third-quarter report included a full-year 2024 earnings outlook cut that sent the insurer’s stock tumbling 12%.
Elevance reported adjusted diluted earnings per share (EPS) of $3.84 for the fourth quarter, beating the Wall Street consensus estimate of $3.77. The insurer also posted a medical loss ratio (MLR) of 92.4%, narrowly beating the consensus of 92.6%. Fourth-quarter operating revenue was $45 billion, a 6% year-over-year increase. Total 2024 operating revenue was $175.2 billion, up 3% from 2023. This increase was largely driven by higher premium yields in the insurer’s Health Benefits segment, which includes individual plans, employer group plans, Medicare and Medicaid.
Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.